Population Pharmacokinetics of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

被引:0
作者
Arantxazu Isla
Alicia Rodríguez-Gascón
Iñaki F. Trocóniz
Lorea Bueno
María Ángeles Solinís
Javier Maynar
José Ángel Sánchez-Izquierdo
José Luis Pedraz
机构
[1] University of the Basque Country,Laboratory of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy
[2] University of Navarra,Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy
[3] Santiago Apóstol Hospital,Intensive Care Unit
[4] Doce de Octubre Hospital,Intensive Care Unit
[5] Paseo de la Universidad no 7,Laboratorio de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia
来源
Clinical Pharmacokinetics | 2008年 / 47卷
关键词
Minimum Inhibitory Concentration; Septic Patient; Meropenem; Continuous Renal Replacement Therapy; Patient Type;
D O I
暂无
中图分类号
学科分类号
摘要
Background and objective: Meropenem is a carbapenem antibacterial frequently prescribed for the treatment of severe infections in critically ill patients, including those receiving continuous renal replacement therapy (CRRT). The objective of this study was to develop a population pharmacokinetic model of meropenem in critically ill patients undergoing CRRT.
引用
收藏
页码:173 / 180
页数:7
相关论文
共 50 条
  • [31] Pharmacokinetics of meropenem in intensive care patients receiving continuous renal replacement therapy
    LJ Giles
    AC Barber
    G Creed
    B Ng
    RJ Beale
    A McLuckie
    Critical Care, 2 (Suppl 1):
  • [32] Antibiotic Dosing in Critically Ill Patients Undergoing Renal Replacement Therapy
    Susla, Gregory M.
    AACN ADVANCED CRITICAL CARE, 2015, 26 (03) : 244 - 251
  • [33] Pharmacokinetics of an Extended 4-hour Infusion of Piperacillin-Tazobactam in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
    Awissi, Don-Kelena
    Beauchamp, Annie
    Hebert, Elisabeth
    Lavigne, Viviane
    Munoz, Danya Lucia
    Lebrun, Genevieve
    Savoie, Michel
    Fagnan, Mylene
    Amyot, Julie
    Tetreault, Nicolas
    Robitaille, Robert
    Varin, France
    Lavallee, Christian
    Pichette, Vincent
    Leblanc, Martine
    PHARMACOTHERAPY, 2015, 35 (06): : 600 - 607
  • [34] Cooling effect of continuous renal replacement therapy in critically ill patients
    Yagi, N
    Leblanc, M
    Sakai, K
    Wright, EJ
    Paganini, EP
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (06) : 1023 - 1030
  • [35] Infection in critically ill pediatric patients on continuous renal replacement therapy
    Santiago, Maria J.
    Lopez-Herce, Jesus
    Vierge, Eva
    Castillo, Ana
    Bustinza, Amaya
    Bellon, Jose M.
    Sanchez, Amelia
    Fernandez, Sarah
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2017, 40 (05) : 224 - 229
  • [36] Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy
    Zhongheng Zhang
    Ni Hongying
    Intensive Care Medicine, 2012, 38 : 20 - 28
  • [37] Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy
    Zhang, Zhongheng
    Ni Hongying
    INTENSIVE CARE MEDICINE, 2012, 38 (01) : 20 - 28
  • [38] Optimal Dosing of Meropenem in a Small Cohort of Critically Ill Children Receiving Continuous Renal Replacement Therapy
    Tan, Wei Wei
    Watt, Kevin M.
    Boakye-Agyeman, Felix
    Cohen-Wolkowiez, Michael
    Mok, Yee Hui
    Yung, Chee Fu
    Chan, Yoke Hwee
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (06) : 744 - 754
  • [39] Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment
    Barrasa, Helena
    Soraluce, Amaia
    Isla, Arantxazu
    Martin, Alejandro
    Maynar, Javier
    Canut, Andres
    Angel Sanchez-Izquierdo, Jose
    Rodriguez-Gascon, Alicia
    JOURNAL OF CRITICAL CARE, 2019, 50 : 69 - 76
  • [40] Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients
    Mattioli, Francesca
    Fucile, Carmen
    Del Bono, Valerio
    Marini, Valeria
    Parisini, Andrea
    Molin, Alexandre
    Zuccoli, Maria Laura
    Milano, Giulia
    Danesi, Romano
    Marchese, Anna
    Polillo, Marialuisa
    Viscoli, Claudio
    Pelosi, Paolo
    Martelli, Antonietta
    Di Paolo, Antonello
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (07) : 839 - 848